Skip to main content
. 2021 Jul 8;12:649336. doi: 10.3389/fphys.2021.649336

TABLE 1.

Diagnoses of kidney diseases based on renal biopsies comparing 2020 with 2019.

Diagnosis 2020 2019 P value
Total – no. 95 114
ANCA GN – no. (%) 15 (15.8) 17 (14.9)
Acute interstitial nephritis – no. (%) 9 (9.5) 18 (15.8)
IgA nephropathy – no. (%) 8 (8.4) 10 (8.8)
Diabetic nephropathy – no. (%) 7 (7.4) 13 (11.4)
FSGS – no. (%) 7 (7.4) 15 (13.2)
Hypertensive nephropathy – no. (%) 7 (7.4) 9 (7.9)
Lupus nephritis – no. (%) 7 (7.4) 9 (7.9)
IgA vasculitis – no. (%) 3 (3.2) 2 (1.8)
Membranous GN – no. (%) 3 (3.2) 4 (3.5)
Postinfectious GN – no. (%) 3 (3.2) 1 (0,9)
Minimal change disease – no. (%) 3 (3.2) 1 (0,9)
Thrombotic microangiopathy – no. (%) 2 (2.1) 2 (1.8)
Amyloidosis – no. (%) 2 (2.1) 1 (0,9)
Monoclonal immune deposition disease – no. (%) 2 (2.1) 2 (1.8)
Others/not representative – no. (%) 17 (17.9) 10 (8.8) 0.6532

Non-parametric between-group-comparisons were performed with Pearson’s Chi-square test. ANCA, anti-neutrophil cytoplasmic antibodies; BUN, blood urea nitrogen; CRP, C-reactive protein; FSGS, focal segmental glomerulosclerosis; GN, glomerulonephritis; IgA, immunoglobulin A; IQR, interquartile range; No., number.